Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV

Saved in:
Bibliographic Details
Main Authors: Kalmanti, Lida (Author) , Saußele, Susanne (Author) , Müller, Martin Christian (Author) , Dietz, Christian (Author) , Hanfstein, Benjamin (Author) , Proetel, Ulrike (Author) , Fabarius, Alice (Author) , Rinaldetti, Sébastien (Author) , Dengler, Jolanta (Author) , Hehlmann, Rüdiger (Author)
Format: Article (Journal)
Language:English
Published: May 2015
In: Leukemia
Year: 2015, Volume: 29, Issue: 5, Pages: 1123-1132
ISSN:1476-5551
DOI:10.1038/leu.2015.36
Online Access:Verlag, Volltext: http://dx.doi.org/10.1038/leu.2015.36
Get full text
Author Notes:L. Kalmanti, S. Saussele, M. Lauseker, M.C. Müller, C.T. Dietz, L. Heinrich, B. Hanfstein, U. Proetel, A. Fabarius, S.W. Krause, S. Rinaldetti, J. Dengler, C. Falge, E. Oppliger-Leibundgut, A. Burchert, A. Neubauer, L. Kanz, F. Stegelmann, M. Pfreundschuh, K. Spiekermann, C. Scheid, M. Pfirrmann, A. Hochhaus, J. Hasford and R. Hehlmann for the SAKK and the German CML Study-Group
Description
Item Description:Gesehen am 12.05.2016
Physical Description:Online Resource
ISSN:1476-5551
DOI:10.1038/leu.2015.36